Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

The changing scenario of drug registration

Patients expectations from drug regulators: The view of the patient advocate

Date

22 Oct 2018

Session

The changing scenario of drug registration

Topics

Bioethical Principles and GCP; Patient Education and Advocacy

Tumour Site

Presenters

Bettina Ryll

Authors

B. Ryll

Author affiliations

Melanoma Patient Network Europe, Melanoma Patient network Europe, 75597 - Uppsala/SE

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

22 Oct 2018

The changing scenario of drug registration - Conclusions

Presenter: Christian Dittrich

Session: The changing scenario of drug registration

22 Oct 2018

The changing scenario of drug registration - Introduction

Presenter: Ian Tannock

Session: The changing scenario of drug registration

Resources:

Slides

Webcast

22 Oct 2018

Reasons for not lowering the bar for new drugs registration

Presenter: Ian Tannock

Session: The changing scenario of drug registration

Resources:

Slides

Webcast

22 Oct 2018

Accelerated / conditional approval as a new regular way of drug registration

Presenter: Francesco Pignatti

Session: The changing scenario of drug registration

Resources:

Slides

Webcast